#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    T-cell lymphoma Postprandial hypoglycaemia White matter lesion Fms-like tyrosine kinase 3 positive Congenital aplastic anaemia Malignant glioma Pyoderma gangrenosum Cutaneous calcification Cardiac amyloidosis Marginal zone lymphoma refractory Leiomyosarcoma recurrent Inclusion body myositis Bronchopulmonary aspergillosis Parkinson's disease Progressive familial intrahepatic cholestasis More trials…

    Learn about Rare Diseases

    Fragile X syndrome – Basic Information Mucopolysaccharidosis III – Diagnostics Splenic marginal zone lymphoma Congenital generalised lipodystrophy – Trials in Disease Richter’s syndrome – Diagnostics Mantle cell lymphoma stage IV – Trials in Disease Gastrointestinal stromal tumour – Diagnostics Congenital hypotransferrinaemia – Trials in Disease Langerhans cell sarcoma – Treatment Medulloblastoma – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    L-Ascorbic Acid Sebetralstat CHLORMADINONE ACETATE Enalapril Maleate Difelikefalin Ondansetron Evg321 Bi 1839100 Gsk4011499 Abc-24F-116 Gentamicin Sulfate Tulisokibart Metoprolol Tartrate Roxadustat Linvoseltamab Urokinase Nemolizumab APROTININ Sulfur Hexafluoride Desloratadine More therapies…

    Learn about Your Condition

    Muscle strain Low cardiac output syndrome Sleep disorder Intermittent claudication Retinal neovascularisation Intestinal ischaemia Arthroscopy Hepatitis D Cerebral palsy Pneumococcal infection Generalised anxiety disorder Choroidal dystrophy Metastases to peritoneum Migraine without aura Tendon disorder More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • Study on the Effect of Clozapine on Immune Response in Patients with Parkinson’s Disease

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Parkinson’s disease
    Investigated Drugs:
    • Clozapine
    France

  • Study on the Use of PRGF and Hypromellose Eye Drops for Treating Dry Eye Disease in Patients

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Dry eye
    Investigated Drugs:
    • Platelet Concentrate
    • Hypromellose
    • Sodium Chloride
    Spain

  • Study of Brentuximab Vedotin with Drug Combination for Untreated CD30-expressing Peripheral T-cell Lymphoma Patients

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Neoplasm malignant
    Investigated Drugs:
    • Brentuximab Vedotin
    • Cyclophosphamide
    • Doxorubicin
    Czechia

  • Monitoring the Effects of Epirubicin, Cyclophosphamide, and Docetaxel in Women with Breast Cancer

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Breast cancer female
    Investigated Drugs:
    • Epirubicin Hydrochloride
    • Cyclophosphamide
    • Docetaxel
    Sweden

  • Study comparing MB04 (etanercept biosimilar) with Enbrel in patients with moderate to severe rheumatoid arthritis who are taking methotrexate

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Rheumatoid arthritis
    Investigated Drugs:
    • Etanercept
    Bulgaria Hungary Poland Romania

  • Study on Vaginal Tamoxifen for Improving Sexual Function in Women with Breast Cancer Experiencing Vulvovaginal Atrophy Symptoms

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Atrophic vulvovaginitis
    Investigated Drugs:
    • Tamoxifen Citrate
    Sweden
Previous Page
1 … 851 852 853 854 855 … 1,674
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!